193 related articles for article (PubMed ID: 8860737)
1. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
Shiina H; Shirakawa H; Yokogi H; Kishi H; Mizutani M; Igawa M; Ishibe T
Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.
Stewart GD; Bariol SV; Grigor KM; Tolley DA; McNeill SA
BJU Int; 2005 Apr; 95(6):791-3. PubMed ID: 15794784
[TBL] [Abstract][Full Text] [Related]
6. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Yagi H; Urakami S; Shirakawa H; Ishibe T
Eur Urol; 1996; 30(1):80-8. PubMed ID: 8854073
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
[TBL] [Abstract][Full Text] [Related]
8. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
9. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.
Wakatsuki S; Watanabe R; Saito K; Saito T; Katagiri A; Sato S; Tomita Y
Cancer Lett; 1996 May; 103(1):11-7. PubMed ID: 8616803
[TBL] [Abstract][Full Text] [Related]
10. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
[TBL] [Abstract][Full Text] [Related]
11. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of nucleolar organizer regions in human bladder cancers by light- and electron-microscopic morphometry.
Shimazui T; Uchiyama Y; Uchida K; Hattori K; Takahashi A; Akaza H; Koiso K
Eur Urol; 1998; 34(5):441-7. PubMed ID: 9803008
[TBL] [Abstract][Full Text] [Related]
13. Biological characteristics of inverted papilloma of the urinary bladder.
Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
Br J Urol; 1996 Jan; 77(1):55-60. PubMed ID: 8653317
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma of the bladder.
Celikel C; Dillioğlugil O; Türkeri LN; Başaran M; Yalçiner A; Küllü S; Akdaş A
Eur Urol; 1995; 28(2):152-7. PubMed ID: 8529742
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
[TBL] [Abstract][Full Text] [Related]
17. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
Helpap B; Loesevitz L; Bulatko A
Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
[TBL] [Abstract][Full Text] [Related]
18. Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.
van Rhijn BW; van der Poel HG; Boon ME; Debruyne FM; Schalken JA; Witjes JA
Urology; 2000 Mar; 55(3):363-7. PubMed ID: 10699611
[TBL] [Abstract][Full Text] [Related]
19. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
Cucer N; Imamoglu N; Tozak H; Demirtas H; Sarac F; Tatlisen A; Oztürk F
Micron; 2007; 38(6):674-9. PubMed ID: 17011198
[TBL] [Abstract][Full Text] [Related]
20. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.
Hansen AB; Bjerregaard B; Ovesen H; Horn T
Histopathology; 1992 Mar; 20(3):257-62. PubMed ID: 1563712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
